Research Report: MRNA Vaccines Market by Type, End-user, and Geography - Forecast and Analysis 2022-2030
A
new analytical report titled as a MRNA Vaccines Market, recently has published by Absolute
Markets Insights to its vast repository. This research report discusses the
numerous key players operating in the global regions. Each of the market
segments has been examined carefully to understand the market clearly. Primary
and secondary research methodologies have been used by the analyst of the
report. This widespread report throws light on different dynamic aspects of the
market.
Report Covers:
·
The report covers forecast and analysis of the
MRNA Vaccines market at the global and regional levels.
·
The report examines the positive and negative
factors affecting market growth.
·
The report details market opportunities.
·
The report analyzes revenue from major industry
players.
·
Market indices are calculated using top-down and
bottom-up approaches.
·
The MRNA Vaccines market has been analyzed using
Porter’s Five Forces Analysis.
·
The market is segmented by type of activity,
type of service and size of organization, which in turn is also segmented by
region.
·
All segments have been assessed taking into
account current and future trends.
·
The report is dedicated to in-depth quantitative
and qualitative analysis of the MRNA Vaccines market.
·
The report includes detailed company profiles of
the major market players.
Click on the
link to get detailed insights:
https://www.absolutemarketsinsights.com/reports/Global-mRNA-Vaccines-Market-2022-2029-1050
According to a report published by AMI, the global mRNA vaccines
market is anticipate to grow at a CAGR of 19.76% during the forecast period.
The rapid advancement in medical technology that promotes the development of
mRNA vaccines, coupled with the growth of infectious diseases globally is a
major reason for the higher growth in revenue in the global mRNA vaccines
market.
Few of the companies profiled in the global mRNA Vaccines Market
report are listed below: Argos Therapeutics,BioNTech
SE,c?IMMUNE,CureVac AG,eTheRNA,Genentech, Inc,Immunomic Therapeutics, Inc.,Moderna,
Inc.,Pfizer Inc.
Global mRNA Vaccines Market
By Clinical Trial Phase
· Preclinical
· Phase I
· Phase II
· Phase III
· Commercial
By Type
· Non-replicating mRNA
· In vivo self-replicating
mRNA
· In vitro dendritic cell
non-replicating mRNA vaccine
By Indication
· Oncology
o Solid Tumors
o Melanoma
o Prostate cancer
o Ovarian cancer
o Glioblastoma
o HPV + Cancer
o Renal Cancer
o Others
· Infectious Diseases
o COVID-19 vaccine
o Rabies
o Lassa, yellow fever
o Respirational syncytial
virus
o Rota
o Malaria
o Universal influenza
o Zika virus
o Multiple sclerosis (MS)
o Epstein-Barr virus (EBV)
o HIV vaccine
o Others
· Rare Diseases
By Vaccine Modality
· Therapeutic
· TME Modulation
· Prophylactic
· DC Vaccine
· T Cell regulation
By Route of Administration
· Intravenous/Intradermal
· Intratumoral
· Intramuscular
By Applications
· Adolescents &
Pediatric
· Adults
By End-User
· Healthcare Facilities
· Government Vaccination
Campaigns
· Research Facilities
· Others
Contact
Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com
Comments
Post a Comment